Cardiovascular Magnetic Resonance Imaging in Myocardial Disease

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 May 22

PMID 38774162

Authors

Oana-Andreea Popa

Mihaela Amzulescu

Claudia Bugeac

Luminita Tomescu

Iulian M Slavu

Valeriu Gheorghita

Rosu Andrei

Adrian Tulin

Affiliations

Soon will be listed here.

Abstract

Cardiovascular magnetic resonance (CMR) is the central non-invasive imaging investigation for the evaluation of myocardial disease. It is the well-established gold standard for measuring cardiac chamber volumes, systolic function, and left ventricular mass, and it brings unique information for therapeutic decisions. In addition, its tissue characterization capability, through T1, T2, and T2* mapping, as well as early and late gadolinium enhancement (LGE) sequences, allows to differentiate in many cases among ischemic, inflammatory, and infiltrative heart disease and permits the quantification of myocardial fibrosis, providing valuable diagnostic and prognostic information. This review aims to highlight the main CMR features of different cardiomyopathies.

References

Higgins C, Herfkens R, Lipton M, Sievers R, Sheldon P, Kaufman L . Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol. 1983; 52(1):184-8. DOI: 10.1016/0002-9149(83)90093-0. View

Castelletti S, Menacho K, Davies R, Maestrini V, Treibel T, Rosmini S . Hypertrophic cardiomyopathy: insights from extracellular volume mapping. Eur J Prev Cardiol. 2021; 28(18):e39-e41. DOI: 10.1093/eurjpc/zwaa083. View

Chan R, Maron B, Olivotto I, Pencina M, Assenza G, Haas T . Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014; 130(6):484-95. DOI: 10.1161/CIRCULATIONAHA.113.007094. View

Kiaos A, Antonakaki D, Bazmpani M, Karvounis C, Rimoldi O, Karamitsos T . Prognostic value of cardiovascular magnetic resonance T1 mapping techniques in non-ischemic dilated cardiomyopathy: A systematic review and meta-analysis. Int J Cardiol. 2020; 312:110-116. DOI: 10.1016/j.ijcard.2020.04.052. View

Bettencourt N, Chiribiri A, Schuster A, Nagel E . Assessment of myocardial ischemia and viability using cardiac magnetic resonance. Curr Heart Fail Rep. 2009; 6(3):142-53. DOI: 10.1007/s11897-009-0021-9. View

Jacquier A, Thuny F, Jop B, Giorgi R, Cohen F, Gaubert J . Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J. 2010; 31(9):1098-104. DOI: 10.1093/eurheartj/ehp595. View

Barison A, Del Torto A, Chiappino S, Aquaro G, Todiere G, Vergaro G . Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown). 2015; 16(10):681-7. DOI: 10.2459/JCM.0000000000000275. View

Seferovic P, Tsutsui H, McNamara D, Ristic A, Basso C, Bozkurt B . Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur J Heart Fail. 2021; 23(6):854-871. DOI: 10.1002/ejhf.2190. View

Captur G, Lopes L, Mohun T, Patel V, Li C, Bassett P . Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2014; 7(6):863-71. PMC: 4237712. DOI: 10.1161/CIRCIMAGING.114.002411. View

10.

Bravo P, Singh A, Di Carli M, Blankstein R . Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2018; 26(1):188-199. PMC: 6374180. DOI: 10.1007/s12350-018-01488-9. View

11.

Emrich T, Halfmann M, Schoepf U, Kreitner K . CMR for myocardial characterization in ischemic heart disease: state-of-the-art and future developments. Eur Radiol Exp. 2021; 5(1):14. PMC: 7990980. DOI: 10.1186/s41747-021-00208-2. View

12.

Petersen S, Khanji M, Plein S, Lancellotti P, Bucciarelli-Ducci C . European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging. 2019; 20(12):1321-1331. DOI: 10.1093/ehjci/jez232. View

13.

Aquaro G, Habtemicael Y, Camastra G, Monti L, Dellegrottaglie S, Moro C . Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis. J Am Coll Cardiol. 2019; 74(20):2439-2448. DOI: 10.1016/j.jacc.2019.08.1061. View

14.

Corrado D, Perazzolo Marra M, Zorzi A, Beffagna G, Cipriani A, De Lazzari M . Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020; 319:106-114. DOI: 10.1016/j.ijcard.2020.06.005. View

15.

Arbustini E, Favalli V, Narula N, Serio A, Grasso M . Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy?. J Am Coll Cardiol. 2016; 68(9):949-66. DOI: 10.1016/j.jacc.2016.05.096. View

16.

McCrohon J, Moon J, Prasad S, McKenna W, Lorenz C, Coats A . Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003; 108(1):54-9. DOI: 10.1161/01.CIR.0000078641.19365.4C. View

17.

Halliday B, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M . Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction. Circulation. 2017; 135(22):2106-2115. PMC: 5444425. DOI: 10.1161/CIRCULATIONAHA.116.026910. View

18.

Grani C, Eichhorn C, Biere L, Murthy V, Agarwal V, Kaneko K . Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol. 2017; 70(16):1964-1976. PMC: 6506846. DOI: 10.1016/j.jacc.2017.08.050. View

19.

Amzulescu M, Rousseau M, Ahn S, Boileau L, De Meester de Ravenstein C, Vancraeynest D . Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study. JACC Cardiovasc Imaging. 2015; 8(8):934-46. DOI: 10.1016/j.jcmg.2015.04.015. View

20.

Caforio A, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M . Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017; 38(35):2649-2662. DOI: 10.1093/eurheartj/ehx321. View